Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Grant/Award of 38,950 BCAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 38,950 | n/a |
| Jul 8, 2026 | Aura Biosciences, Inc. (AURA) | Grant/Award | 30,000 | n/a |
| Apr 23, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 204,643 | n/a |
| Feb 27, 2026 | Mereo BioPharma Group plc (MREO) | Grant/Award | 66,000 | n/a |
| Feb 18, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 4,750 | n/a |
| Jan 30, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 355,000 | n/a |
| Nov 26, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Gift | 300,000 | n/a |
| Nov 18, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 3,570 | n/a |
| Nov 7, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 1,463,134 | n/a |
| Aug 19, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Exercise/Conversion | 3,562 | n/a |